The current data indicated that IF1 expression was present in 68.6% (59/86) of glioma tissues, while only 20.0% (4/20) of NB tissues exhibited a signal for IF1 expression (P<0.05; Fig. 1). This evidence concerns the gene ATP5IF1 and central nervous system cancer.